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Although histone acetylation is critical for maintaining embryonic stem cell pluripotency, the molecular
machinery involved remains poorly understood. Li et al. (2012) now show that Mof, a MYST family histone
acetyltransferase, functions as a coactivator of Nanog-mediated transcription, maintains the expression of
pluripotency-associated genes, and primes developmental genes for differentiation.Embryonic stem cells (ESCs) are en-
dowed with the capacity to self-renew
while maintaining the ability, if appropri-
ately stimulated, to give rise to all cell
types in the body. Numerous studies
that have searched for mechanisms
governing self-renewal and differentiation
of ESCs have highlighted a key role for
chromatin in regulating these processes.
In particular, acetylation of nucleosomal
histones that occurs on conserved
lysine residues and correlates with open,
transcriptionally permissive chromatin
has long been associated with the
maintenance of an undifferentiated state.
Indeed, overall levels of acetylated
histones are high in ESCs and are
reduced upon induction of differentiation.
Maintaining elevated histone acetylation
with histone deacetylase (HDAC) inhibi-
tors prevents differentiation and improves
somatic cell reprogramming (Gaspar-
Maia et al., 2011). Histone acetylation is
catalyzed by several families of histone
acetyltransferases (HATs), which have
been well studied in several different
systems. Nonetheless, little is known
about how specific HATs regulate the
pluripotent state. In this issue of Cell
Stem Cell, Dou and colleagues (Li et al.,
2012) demonstrate that Mof, a HAT of
the MYST family, functions to maintain
self-renewal and to ensure proper differ-
entiation of ESCs.
Mof (male absent on the first), also
called MYST1 or KAT8, is a major enzyme
that catalyzes H4K16 acetylation, which is
a modification that prevents nucleosomal
chain compaction. Ablation of Mof inmice
results in a global reduction of H4K16
acetylation and peri-implantation lethality
(Rea et al., 2007). To elucidate the func-
tion of Mof in ESCs, Dou and colleaguesestablished inducible Mof knockout ESC
lines. Mof depletion in these cells resulted
in profound morphological changes, the
loss of both alkaline phosphatase activity
and the ability to form embryoid bodies,
and eventually cell death. These pheno-
typic changes were accompanied by
a widespread impact on the ESC tran-
scriptome with a reduction in expression
of the key pluripotency factors Nanog,
Oct4, Sox2, and Esrrb and an increase
in expression of differentiation genes.
Molecular analyses revealed that pluripo-
tency factors are direct Mof targets.
Furthermore, a significant and specific
overlap between Mof and Nanog target
genes was identified: 80% of Nanog
targets were bound by Mof at their
promoters, suggesting that Mof may
serve as a coactivator of Nanog-mediated
transcription. Interestingly, forced ex-
pression of Nanog in Mof/ ESCs
partially suppressed the Mof null pheno-
type without restoring H4K16 acetyla-
tion. Thus, although Mof is indispensable
for regulation of Nanog and other core
pluripotency factors, there may be a
redundancy with other chromatin modi-
fiers for regulating downstream target
genes.
To further investigate Mof function,
Mof binding was analyzed genome-wide.
The majority of binding peaks were asso-
ciated with gene-rich regions. When
analyzed within 12 kb intervals surround-
ing the transcription start sites (TSS), the
binding was enriched at the TSS. In
addition, 50% of binding peaks were
located throughout the gene body. These
findings drew a parallel with the results
obtained earlier in flies, where it was
demonstrated that the bimodal distri-
bution of Mof is due to its dynamic associ-Cell Stem Cell 1ation with two distinct protein complexes.
The MOF-NSL complex is enriched at
the TSS and functions as a global facili-
tator of transcription, whereas the dosage
compensation complex (DCC), also
known asMOF-MSL complex, is enriched
at the 30 regions. The MOF-MSL complex
stimulates transcription of X-linked genes
via Mof-dependent H4K16 acetylation
and, at the same time, restricts tran-
scriptional activity via a repressive func-
tion of MSL proteins, resulting in a
precise 2-fold increase in the expression
of target genes in male flies (Prestel
et al., 2010).
In mammalian cells, Mof physically
interacts with Wdr5, a core component
of the H3K4 histone methyltransferase
complex MLL (Dou et al., 2005). shRNA-
mediated depletion of Wdr5 in ESCs
significantly attenuates the expression of
the pluripotency factors Nanog, Oct4,
and Sox2 and induces cell differentiation
(Ang et al., 2011), thus resembling the
phenotype observed in Mof/ ESCs.
Following up on this lead, the authors
took a closer look at Mof and Wdr5 bind-
ing, and H3K4me3 levels in ESCs. Strik-
ingly, one-third of all Wdr5/H3K4me3
peaks overlapped with Mof peaks. The
joint MOF/Wdr5/H3K4me3 peaks were
overwhelmingly located around the TSS
whereas Mof peaks that lacked Wdr5
binding were mostly located along the
gene bodies (Figure 1A). This pattern is
reminiscent of the bimodal distribution
of the Mof complexes in flies. Given
that genes with joint Mof/Wdr5 binding
had a tendency to be downregulated
upon Mof depletion and were enriched
for stem cell maintenance functions,
the authors next tested whether Mof
mediates the recruitment of Wdr5 at1, August 3, 2012 ª2012 Elsevier Inc. 139
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Figure 1. Histone AcetyltransferaseMof Is an Essential Regulator of
Embryonic Stem Cell Self-Renewal
Mof binding is enriched in the TSS-proximal promoter regions and also
detected in the coding regions. At promoters, including those of Nanog and
Sox2, Mof activates transcription via the recruitment of Wdr5, a core subunit
of the histone methyltransferase complex MLL, and subsequent H3K4
trimethylation (A). The authors hypothesize that Mof bound to gene coding
regions likely resides in the repressive complex. This complex maintains
open chromatin at target loci via Mof-mediated H4K16Ac, whereas the hypo-
thetical repressor activity limits transcription from the nearby promoter. This
proposed mechanism would ‘‘prime’’ target genes for rapid activation upon
dissociation of the complex, for example during differentiation or in Mof/
ESCs (B).
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Indeed, both Wdr5 binding
and H3K4me3 levels were
reduced at Nanog, Sox2,
and Utf1 promoters inMof/
ESCs.
In contrast to promoter-
bound Mof/Wdr5 targets
that were downregulated in
Mof/ cells, a significant
number of genes with MOF
peaks in the coding regions
were upregulated in Mof/
ESCs. These genes were en-
riched for functions associ-
ated with cell differentiation
and tissue development. The
authors therefore propose
that in the coding regions,
the Mof likely resides in the
repressive MOF-MSL com-
plex, a mammalian counter-
part of the fly DCC com-
plex (Li and Dou, 2010). In
this model, Mof-mediated
H4K16Ac creates a transcrip-
tionally permissive chromatin
state at the target locus,
whereas the hypothetical re-
pressor protein restricts tran-scription from the nearby promoter.
Such a mechanism would ‘‘prime’’ target
genes for rapid activation upon dissocia-
tion of the complex, which could occur
either upon induction of differentiation or
in Mof/ ESCs (Figure 1B).
In summary, the work by Dou and
colleagues significantly expands our cur-
rent knowledge of the molecular mecha-
nisms underlying ESC self-renewal and
differentiation. The critical and unique
role of Mof as a positive regulator of the
ESC transcriptional network sets it apart
from the other HATs, including Tip60,
p300, and Gcn5, which appear to have
little effect on pluripotency gene expres-
sion, but rather, mediate downstream
differentiation processes (Fazzio et al.,
2008). In-depth analyses of these HATs
will help further understand their unique
and overlapping roles in ESC mainte-
nance and differentiation.
The functional interplay between Mof,
Wdr5, and H3K4me3 at the pluripotency
gene promoters revealed by this study140 Cell Stem Cell 11, August 3, 2012 ª2012may help explain why inactivation of
different components of the MLL com-
plexes, namely Wdr5, Dpy30, and Rbbp5,
in ESCs results in very different pheno-
types. In contrast to Wdr5, whose inacti-
vation, similar to that of Mof, attenuates
the expression of pluripotentcy genes
and induces ESC differentiation, deple-
tion of Dpy30 or Rbbp5 has no effect on
pluripotency gene expression despite
causing a decrease in global H3K4me3
levels and misregulated expression of
developmental genes (Jiang et al., 2011).
One may speculate that while the Mof-
Wdr5 MLL complexes selectively target
self-renewal genes, the Mof-independent
Dpy30-Rbbp5 MLL complexes preferen-
tially target developmental genes. How
these distinct complexes find their res-
pective targets in the genome is the key
question to be addressed in the future
studies.
The proposed ability of the coding
region-bound Mof complexes to maintain
target genes ready for activation whileElsevier Inc.at the same time suppress-
ing their activity in ESCs
potentially defines a novel
‘‘priming’’ mechanism that is
distinct from the ‘‘bivalent’’
chromatin domains at the
gene promoters (Bernstein
et al., 2006). It will be impor-
tant to determine whether
such a mechanism is re-
stricted to ESCs or utilized
more broadly by other stem
cells, for instance, neural or
hematopoietic stem cells, to
control activity of genes
needed in downstream differ-
entiation processes.
Taken together, these
findings represent an impor-
tant advance in understand-
ing the chromatin-modifying
machinery and its role in
ESC self-renewal and differ-
entiation and pave the way
for new and exciting future
studies.
REFERENCES
Ang, Y.S., Tsai, S.Y., Lee, D.F.,
Monk, J., Su, J., Ratnakumar, K.,Ding, J., Ge, Y., Darr, H., Chang, B., et al. (2011).
Cell 145, 183–197.
Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M.,
Huebert, D.J., Cuff, J., Fry, B., Meissner, A.,
Wernig, M., Plath, K., et al. (2006). Cell 125,
315–326.
Dou, Y., Milne, T.A., Tackett, A.J., Smith, E.R.,
Fukuda, A., Wysocka, J., Allis, C.D., Chait, B.T.,
Hess, J.L., and Roeder, R.G. (2005). Cell 121,
873–885.
Fazzio, T.G., Huff, J.T., and Panning, B. (2008). Cell
Cycle 7, 3302–3306.
Gaspar-Maia, A., Alajem, A., Meshorer, E., and
Ramalho-Santos, M. (2011). Nat. Rev. Mol. Cell
Biol. 12, 36–47.
Jiang, H., Shukla, A., Wang, X., Chen, W.Y.,
Bernstein, B.E., and Roeder, R.G. (2011). Cell
144, 513–525.
Li, X., and Dou, Y. (2010). Epigenetics 5, 5.
Li, X., Pandey, R., Buyun, J.S., Gardner, K., Qin, Z.,
and Dou, Y. (2012). Cell Stem Cell 11, this issue,
163–178.
Prestel, M., Feller, C., Straub, T., Mitlo¨hner, H., and
Becker, P.B. (2010). Mol. Cell 38, 815–826.
Rea, S., Xouri, G., and Akhtar, A. (2007). Oncogene
26, 5385–5394.
